With the help of advanced technology, this is possible. Greg Meyers, Chief Digital and Technology officer at Bristol Myers Squibb (BMS), highlights how AI now analyzes huge datasets and predicts the drugs most likely to succeed, before any lab tests begin.

→ View original post on X — @nvidiaai